, is Administrative Director and Principal Investigator for the Center for Technology and Health. She received her Ph.D. in Clinical Psychology at the University of Delaware, and completed a predoctoral internship in Pediatric Psychology at the A.I. DuPont Hospital for Children and a postdoctoral fellowship in Addiction Psychology at the Medical College of Virginia, Virginia Commonwealth University.
Dr. Acosta’s research activities have focused on novel adaptations of evidence-based substance abuse interventions in non-traditional settings (e.g., psychiatric, medical, remote/telephone, web-based, mobile) that may improve the reach and acceptability of these treatments for vulnerable populations. She has served as Project Manager, Co-Investigator, and Principal Investigator on several federally-funded projects. She has conducted research focused on developing and evaluating substance abuse interventions for medically ill patients (i.e., patients with chronic pain, patients requiring organ transplant) and youth, including adolescent and young adult smokers and teens with substance use disorders. Currently, Dr. Acosta serves on several projects examining the impact of web-based behavior therapy for methadone maintenance clients, adolescents with substance use disorders, OEF/OIF/OND Veterans, and patients with chronic pain. She is Principal Investigator on a study designed to develop and evaluate a mobile intervention for clients in methadone maintenance treatment.
, is a Principal Investigator in the Center for Technology and Health. His work examines how methodologies and evidence-based findings from the learning sciences can be applied to technology-based health interventions. His current research, funded by NIDA, examines how the content of educational video segments, delivered on affordable handheld computers, can be optimized for greatest effectiveness. As part of this research, Dr. Aronson is creating a set of original videos about HIV testing and prevention based on differing theories of education and multimedia learning. He will also create an application to integrate delivery of the videos with pre- and post-intervention data collection instruments, and then implement a clinical trial to determine which videos produce the best results. The trial will be conducted in an exceptionally high volume, urban emergency department that serves a diverse population of patients, including many who are at high risk.
Dr. Aronson earned a Ph.D. in Educational Communication and Technology from New York University, and an M.A. in Documentary Film and Video from Stanford University. He was also a postdoctoral research fellow in the Behavioral Sciences Training Program in Drug Abuse Research at Public Health Solutions/NDRI. Before starting his doctorate, he was Assistant Professor of Digital Media at Ramapo College.
is a Principal Investigator with NDRI’s Institute for Special Populations Research (ISPR) who specializes in ethnographic, historical and mixed-methods public health and public policy research. His current project is a 4-year study of Opioid Use/Misuse and Overdose Risk among veterans (R01DA036754) that will help determine ecological, structural, and psychosocial aspects of opioid use and overdose risk. Dr. Bennett is also a Project Director with ISPR on a study examining mental health, substance use and civilian transition among recent veterans in NYC. His other research focuses on substance use and disaster, historical and contemporary perspectives on drug use and drug policy, and drug markets. Dr. Bennett earned a Ph.D. in Applied History and Policy from Carnegie Mellon University, and an M.P.A. in Public Policy from the University of Pittsburgh. He also completed a 2-year postdoctoral fellowship in the Behavioral Sciences Training Program in Drug Abuse Research sponsored by the National Institutes of Health.
, is a Principal Investigator in the Institute for Special Populations Research and the Center for Drug Use and HIV Research. She is currently Principal Investigator with Dr. Eloise Dunlap on a study funded by the NICHD examining HIV risk and substance use among low-income heterosexual Black women with multiple male partners. Dr. Benoit was project director for this study’s predecessor, which examined multiple sexual partnering and HIV risk among low-income heterosexual Black men (PI: Eloise Dunlap, Ph.D.). Both studies employ sexual script theory to investigate and analyze learned sexual norms and scripts, and involvement in drug use and sales, as contributors to multiple-partner risk. Dr. Benoit’s previous independent work focused on HIV risk among substance-using Black men who have sex with men and women (MSMW) but do not identify as gay or homosexual and do not disclose their same-sex activity to their female partners.
Before joining the staff of NDRI, Dr. Benoit taught sociology at Sarah Lawrence College in Bronxville, NY. She was also a postdoctoral research fellow in the Behavioral Sciences Training Program in Drug Abuse Research at PHS/NDRI from 2001 to 2003.
, is a quantitative social psychologist and a graduate of the New School for Social Research. Dr. Cleland is a co-investigator on a study funded by the National Institute of Allergy and Infectious Diseases, which examines AIDS clinical trial participation among ethnic minorities and women. He serves as a statistical consultant for the Center for Drug Use and HIV Research and the Center for the Integration of Research & Practice.
, is a Principal Investigator with the Center for Technology and Health. He is also an Associate Professor in the Department of Psychology at the University of Florida, and a Licensed Psychologist in the state of Florida. Dr. Dallery received his Ph.D. in Clinical Psychology at Emory University in 1999, and completed a postdoctoral fellowship at the Johns Hopkins University School of Medicine in Behavioral Pharmacology.
Dr. Dallery’s research involves novel applications of internet-based behavioral interventions for cigarette smoking. He has conducted several studies suggesting that a novel, science-based intervention can promote smoking cessation. The treatment employs breath-based measures of smoking status, which also allows objective verification of treatment effects. In collaboration with colleagues, he is involved in extending the application to high-risk groups such as adolescents, pregnant women, and rural smokers. The intervention eliminates distance as a barrier, which should allow widespread dissemination of an effective behavioral intervention. The results also encourage the application of internet-based technology to other health-related behavior. Accordingly, he is also interested in integrating breath-based diagnostic technology (for medication compliance, blood glucose monitoring, other illicit drugs) with innovations in behavioral treatments. Currently, Dr. Dallery is conducting a randomized trial investigating the short- and long-term efficacy of the internet-based treatment for cigarette smoking.
is an internationally recognized expert in the treatment of substance abuse, and acknowledged as the leading authority on treatment and research in therapeutic communities. He holds a Ph.D. Degree in psychology from Columbia University. He is founder, former Director, and now senior scientist of the Center for Therapeutic Community Research (CTCR) established by a National Institute on Drug Abuse (NIDA) grant to the National Development and Research Institutes, Inc. (NDRI). CTCR has also served as a training site for NIDA Humphrey Fellows. Currently he serves as Science Director of the Behavioral Science Training Program (BST) at NDRI.
He is a Clinical Professor of Psychiatry at New York University School of Medicine where he provides training in therapeutic community practice and research to psychiatric fellows, psychologists, pre- and post-doctoral graduates, nurses and social workers. He was a Vice President and Director of Research and Evaluation at Phoenix House from its inception through 1988, and served as Director of Research and Training at Therapeutic Communities of America (TCA) from 1988 to 1991. He served as coordinator of the TCA subcommittee on Criminal Justice which developed national standards for accreditation of therapeutic community programs in correctional settings
Dr. De Leon has published over 165 scientific papers and chapters, has authored and edited seven books and monographs including The Therapeutic Community: Theory, Model and Method, considered the definitive text in the field. He serves as consulting editor, guest and contributing editor to several national and international journals.
In addition to his research, Dr. De Leon has made notable contributions in the area of professional education and clinical practice. Currently he serves as a senior advisory member of the American Academy of Health Care Providers in the Addictive Disorders; the main national organization certifying addiction specialists from all professional disciplines. He serves on the Expert Advisory Committee on Chemical Dependency of the American Psychological Association College of Professional Psychology. He is a founding member of the New York State Psychological Association's Division on Addictions. A founding member of the American Psychological Association's Division 50 on Addictions, on which he also served as president (1996-97).
Dr. De Leon regularly provides clinical practice and research training to treatment agencies, most recently in correctional settings. Additionally, his textbook is the basis for TC national training curricula available through the Substance Abuse and Mental Health Services Administration (SAMHSA). Some of his own trainings are available on videos from the Addiction Training and Technology Centers (ATTC), Amity Foundation and University of California at San Diego (CCARTA). He has maintained a private clinical practice in New York City for over 40 years
Dr. De Leon is a recipient of several awards including: the Therapeutic Communities of America award for Distinguished Service (1978); the Eugenia Maria De Hostos and Jose Marti award for dedication and contribution to the field of psychology presented by the New York Society of Clinical Psychologists (1984); the award for Distinguished Service to Psychology (1990) presented by the Society of Psychologists in Addictive Behaviors (SPAB); the 1993 National Institute on Drug Abuse (NIDA) Pacesetter Award for Outstanding Leadership in Pioneering Research on the Therapeutic Community Approach to Drug Abuse Treatment; the New York State Governor’s Lifetime Achievement Award (2000); The European Federation of Therapeutic Communities (EFTC) Award for Distinguished Contribution to Science and Practice (2005).
Books and Monographs
, is Director of Research for the Baron Edmond de Rothschild Chemical Dependency Institute at Beth Israel Medical Center, a Senior Research Fellow with the National Development and Research Institutes, Inc., and Professor of Clinical Psychology (in Psychiatry) at Columbia University.
As a leader in the fields of AIDS and injecting drug use since the early 1980s, Dr. Des Jarlais has published extensively on these topics including papers in the New England Journal of Medicine, the Journal of the American Medical Association, Science and Nature. He has been particularly active in international research, having collaborated on studies in twenty-five different countries. He serves as a consultant to various institutions, including the Centers for Disease Control and Prevention, the National Institute on Drug Abuse, the National Academy of Sciences and the World Health Organization. He is a former commissioner for the US National Commission on AIDS, and is currently a Core Group Member of the UNAIDS Reference Group on HIV and Injecting Drug Use. In 2010 Dr. Des Jarlais was elected to the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board (SAB).
is a psychologist and Project Director with the Institute for Infectious Disease Research at NDRI. He received his PhD from the City University of New York in 2010, and is completing a postdoctoral research fellowship in the NIDA-funded Behavioral Sciences Training Program in Drug Abuse Research administered by Public Health Solutions. His research interests represent a commitment to understanding the impact of psychological, social and contextual factors as they relate to sexual health, substance use, and HIV/STI prevention. Dr. Downing joined IIDR in 2013 to work with Dr. Sam Friedman on the Transmission Reduction Intervention Project (TRIP).
At the present time, Dr. Eloise Dunlap is Director of the Institute for Special Population Research (ISPR) and Principal Investigator. Especially pertinent to her work is her interest in understanding the underlying dynamics and context of social and cultural determinates of behavior which commonly occurs among inner-city low income residents. Much of her current work focuses upon various aspects of the illicit drug market, impact of disasters on drug use and sales, treatment, HIV risks and health services and impact of drugs on family and households. In addition, Dunlap has a long history of mentoring NIDA-funded junior researchers including three new minority investigators under the NIH-funded Research Supplements to Promote Diversity in Health-Related Research. Dr. Dunlap has also actively fostered 11 high school and 4 undergraduate students under Summer Research with NIDA for Underrepresented Students.
Recent NIH-funded studies consist of: Disruption and Reformulation of Illicit Drug Markets among New Orleans Evacuees, Stages of Drug Market Disruption and Reformulation in Disaster Cities, Video Games' Role in Developing Substance Use, Multiple Sexual Partnering & HIV Risks Among Low Income Heterosexual Black Men, and Heterosexual Black Females: Socialization and HIV Risks in Scripts and Practices.
received her PhD from New York University School of Social Work where her dissertation analyzed in-depth interviews with deaf adults conducted in American Sign Language (ASL) to study the ways that Deaf culture influences HIV-related health behaviors. Her extensive research experience includes the use of qualitative and quantitative research methods to develop and implement culturally and linguistically accurate computer-based surveys in ASL to study substance use, tobacco use, mental health, and HIV. Through NDRI affiliate Social Sciences Innovations Corporation (SSIC) she is currently working to develop a computer-based HIV Curriculum for use with Deaf High School Students and a self-administered, computer-based, Depression Screener in ASL. Dr. Eckhardt has several years of clinical experience with Deaf individuals and has developed comprehensive county wide service programs for Deaf individuals and their families.
, has been engaged in research on emerging issues in infectious diseases for 25 years, including 20 years conducting community-based research with people who inject illicit drugs (PWIDs). The goals of this work are to develop a multidimensional understanding of the factors associated with health and illness in these populations, and to develop and evaluate policies and interventions to improve their health. This research examines social, structural, behavioral, and biological factors associated with health conditions among PWIDs — including HIV, hepatitis B and C, other viral infections, tuberculosis, abscesses, heroin overdose, and other causes of morbidity and mortality in substance-using populations. Dr. Edlin’s research team has developed or evaluated pioneering interventions including needle exchange, street-based hepatitis B vaccination, street-based abscess care, and naloxone distribution to prevent fatal heroin overdose.
Two community-based studies currently underway in New York focus on how and why the hepatitis C virus (HCV) continues to spread among people who inject illicit drugs despite access to needle exchange, and on overcoming the barriers to access to hepatitis C treatment in people currently injecting illicit drugs. The Swan Project is a study of the clinical, behavioral, virologic, and immunologic characteristics of acute HCV infection among high-risk young persons who inject illicit drugs. The Collaborative Hepatitis Outreach and Integrated Care Evaluation Study (CHOICES) is a randomized trial of a novel multidisciplinary, integrated care program carried out in collaboration with a community-based needle exchange program in Harlem that provides antiviral therapy for hepatitis C to persons who inject illicit drugs.
In the policy arena, Dr. Edlin has been at the forefront of efforts to win access to hepatitis C treatment for illicit drug users. He was the first to publicly and prominently challenge the NIH recommendation to withhold hepatitis C treatment from active illicit drug users. The following year, the NIH invited him to address its Consensus Development Conference as an expert speaker on hepatitis C in injection drug users. The Consensus Panel adopted his recommendations, rescinding its recommendation against treating drug users for hepatitis C and recommending hepatitis C prevention, testing, and treatment programs for injection drug users and incarcerated persons.
Dr. Edlin has also had 20 years’ experience as a research mentor, providing guidance in clinical and epidemiologic research study conceptualization, design, implementation and management, data analysis and interpretation, manuscript development and submission, and grant writing, resulting in more than 25 publications in peer-reviewed journals first-authored by trainees.
is a Principal Investigator and cultural and medical anthropologist who focuses on pathways to substance use and behavioral addictions. Elliott’s interests in vulnerable subcultures and populations led him to the Institute for Special Populations Research (ISPR) at NDRI following his Ph.D. work (New York University, 2006) with emergent subcultures of psychedelic drug use. Since then, he has collaborated with senior researchers, Bruce Johnson, Eloise Dunlap, and Andrew Golub on studies of marijuana use (R01DA013690), Hurricane Katrina's evacuees (R01DA021783), and veterans’ health (R01AA020178). Dr. Elliott recently served as principal investigator on a 3-year study of developmental relationships between video game and substance use (R01DA027761) and is now serving as project director and co-investigator on a study of military veterans’ overdose risks and prevention efforts (R01DA036754).
(sociology) is Director of the Institute for Infectious Disease Research at National Development and Research Institutes, Inc. and the Director of the Interdisciplinary Theoretical Synthesis Core in the Center for Drug Use and HIV Research, New York City. (He is also a prior Director of the Research Methods Core in the Center for Drug Use and HIV Research.) He also is associated with the Department of Epidemiology, Johns Hopkins University, and with the Dalla Lana School of Public Health, University of Toronto. Dr. Friedman is an author of about 450 publications on HIV, STI, and drug use epidemiology and prevention, including pieces in Nature, Science, Scientific American, the New England Journal of Medicine, JAMA, the American Journal of Epidemiology, and the American Journal of Public Health.
Recent research projects have included a review paper (AIDS, 2006) on the social research needs of the AIDS field; a study of social factors, social networks and HIV, STI and other blood-borne viruses among youth and drug injectors in a high-risk community; research on the impact of economic and political crises on HIV risk in Buenos Aires; a study of how some long-term drug injectors remain uninfected with HIV and HCV (i.e., how they Stay Safe); a study of socioeconomic and policy predictors of the extent of injection drug use, of HIV epidemics, and of HIV prevention efforts in US metropolitan areas; a longitudinal study of how the HIV epidemics and related programs among people who inject drugs, men who have sex with men, and heterosexuals in US metropolitan areas are associated with each other (with Hannah Cooper (Contact PI) and Ron Stall); the development of novel measures to understand how structural interventions or Big Events/Complex Emergencies affect variables related to HIV risk networks and behaviors; research on why women injectors who have sex with women are at enhanced risk for HIV and other infections; and research on preventing transmission of HIV by the recently infected. He has engaged in many international collaborative projects with the WHO MultiCentre Study of Drugs and HIV and with researchers in Argentina, Australia, Brazil, Canada, Greece, the Netherlands, Spain, Ukraine and other countries.
He has also written on international HIV topics such as war and HIV; sociopolitical transitions and HIV; and drug users’ organizations (user groups) as actors globally against HIV. He has been Associate Editor for Social Science of the International Journal of Drug Policy and is or has been on the editorial boards of AIDS, JAIDS, AIDScience, a Web venture for the American Association for the Advancement of Science, AIDS Education and Prevention, The Drug and Alcohol Professional, and Harm Reduction Journal. Honors include the International Rolleston Award of the International Harm Reduction Association (2009), the first Sociology AIDS Network Award for Career Contributions to the Sociology of HIV/AIDS (2007), a Lifetime Contribution Award, Association of Black Sociologists (2005) and a NIDA Avant Garde Award for research on Preventing HIV Transmission by Recently-Infected Drug Users. He has published many poems in a variety of publications. He is the author of two poetry chapbooks (Murders most foul: Poems against war by a World Trade Center survivor. Central Jersey Coalition against Endless War. 2005 andNeedles, drugs, and defiance: Poems to organize by. North American Syringe Exchange Network. 1999) and a book of poetry (Seeking to make the world anew: Poems of the Living Dialectic. 2008. Lanham, Maryland: Hamilton Books).
With his a background in Statistics and Computer Science, Mr. Fong provides technical support and conducts statistical analyses and data management for various research projects at NDRI. Mr. Fong has extensive experience as a SAS statistics programmer and also works with a variety of other statistical and data management programs such as SPSS, R, Mplus, QDS, LISREL, and Teleform. Further, he has considerable experience conducting statistical analyses with data from prevalence studies and clinical trials. He is well-versed in a number of statistical quantitative analytic techniques including random regression, general estimating equation, power analysis, structural equation modeling, and latent class analysis. These statistical skills have been applied to a diverse number of research domains including peer mentoring for high risk youth with HIV parents, drug abusing inmates receiving buprenorphine treatment, juvenile drug abusing offenders in the criminal justice system, and dually-diagnosed persons receiving dual-focus mutual aid. Currently, he is the Project Director/lead statistician on a large national project which assesses opioid use among patients enrolling in methadone treatment programs. He previously served as the Data Manager/Analyst for NDRI’s Institute for Treatment and Services Research and was the Senior Methodologist for NDRI’s Center for Therapeutic Community Research.
is a Deputy Director of the Institute for International Research on Youth at Risk (IIRY) at NDRI; a Co-Investigator on a study of young injection drug users in the Socialist Republic of Vietnam; a Co-Investigator on a study of sexually active HIV positive men who have sex with men; and a Co-Investigator on a study of the impact of Hurricane Katrina on drug users in New Orleans. Over the past several years, Dr. Goldsamt has served as Principal Investigator or Co-Investigator on NIH-funded studies looking at HIV risk among injection drug users, youth, and men who have sex with men. Dr. Goldsamt has also conducted numerous program and training evaluations, and serves as the Evaluator for NDRI’s Training Institute. Dr. Goldsamt is also a licensed clinical psychologist in New York State, and maintains a psychotherapy practice in Great Neck, N.Y.
is a Principal Investigator in The Institute for Infectious Disease Research at NDRI. She received her MPH in Public Health Education from Johns Hopkins University and her PhD in Epidemiology from Columbia University. Her research for and about deaf individuals has involved computer based surveys in American Sign Language on drug abuse, mental health and HIV. She has also conducted intervention studies of street-recruited drug users including those who are HIV positive, aimed at improving their use of health and medical services. Dr. Goldstein who maintains a public health focus in her research, has published on these and related topics.
, received his Master’s in Public Health from West Virginia University. Mr. Goli has experience in both Medical/Clinical Epidemiology and Biostatistics and Information Technology. For five years following completion of his Bachelor of Medicine and Surgery degree from India, Mr. Goli worked in rural and tribal populations in India implementing national programs including but not limited to Revised National Tuberculosis Control Program (RNTCP), Integrated Disease Surveillance Project (IDSP), National Program for Control of Blindness (NPCB), National Vector Borne Disease Control Program (NVBDCP), National AIDS Control Program, National Polio Prevention Program as well as providing in-patient and outpatient services for 35,000 population. His interest in population health continued and led to the degree in Public Health.
, is a Principal Investigator in The Institute for Special Populations Research. He received his Ph.D. in public policy analysis from Carnegie Mellon University. His research focuses on understanding social problems in context with an aim towards developing appropriate public policy responses. His studies have examined trends in drug use, the larger context of use, causes and consequences of use, and the efficacy of policies and programs as well as associated issues related to violence, crime, policing, poverty, and families. His work has appeared in the American Journal of Public Health, Criminology and Public Policy, and Journal of Drug Issues. He is currently preparing a special issue for Substance Use and Misuse on “Drugs, Wars, Soldiers and Veterans.”
Dr. Golub is a leading authority on the analysis of drug use trends. In the course of his work, he has developed a descriptive model for tracking the dynamics of drug epidemics which regularly emerge and for projecting their expected near-term impact. Epidemics like other diffusion phenomena tend to progress from incubation within a limited social context through a period of rapid expansion to a plateau of widespread use and finally into an extended decline phase. Dr. Golub has used this framework to analyze the Heroin Injection Epidemic which peaked in the 1960s and early 1970s, the Crack Epidemic with peaked in the mid to late 1980s, the Marijuana/Blunts Epidemic which emerged in the 1990s, the Methamphetamine Epidemic that may be starting to draw to a close in the 2010s, and the currently prevailing epidemic in prescription opiate use. Dr. Golub has also examined the gateway phenomenon and identified ways in which drug use pathways vary with cultural trends over time and across individual circumstances.
Dr. Golub is currently leading two major public health studies. The Veterans Reintegration Project examines the challenges faced by veterans returning from Afghanistan and Iraq to New York’s inner-city neighborhoods. The study focuses on the significance of substance abuse and its relationship with other mental health problems, and reintegration into family, work and community life within the complex of problems prevailing in low-income communities. The Coparenting Project examines the structure of daily life within low-income African American households where relationships between men and women often do not endure. The analysis explores the strengths of the contributions of the cohabiting partners to adolescent development as well as the problems associated with the transient nature of these relationships.
, is a Principal Investigator with NDRI’s Center for Technology and Health who specializes in qualitative, ethnographic and mixed-methods research on the social aspects of substance abuse and HIV/AIDS. She is currently Principal Investigator of a NIDA-funded study examining the social contexts of drug use and HIV/HCV risk among young, opioid-using immigrants from the former Soviet Union and Co-Investigator/Ethnographer for a 5-year, NIDA-funded study of nonmedical prescription opioid use and associated patterns of HIV/HCV/STI risk among young adults in New York City. She is also Principal Investigator of a pilot study, awarded by the Center for Technology and Behavioral Health at Dartmouth College, to develop and implement an innovative method for evaluating opioid-maintained chronic pain patients’ engagement in a web-based, self-management intervention. Dr. Guarino received her Ph.D. in Anthropology from the University of Arizona.
, is Senior Principal Investigator and Director of the Institute for Biobehavioral Health Research at NDRI. He completed the Statistics and Research Design and Behavioral Medicine doctoral programs at the University of Memphis. He also completed postdoctoral fellowships in Health Psychology with the US Air Force (USAF) and in Cardiovascular Disease with the American Hospital Association’s Health Forum. Dr. Haddock is a military veteran, having served both on activity duty and active reserve of the USAF. He has published over 160 scientific papers, addressing tobacco control, obesity, fitness and work capacity, and cardiovascular disease and has received research funding from the National Institutes of Health (NIH), DoD, Department of Homeland Security, American Heart Association, and American Legacy Foundation as a Principal or Co-Investigator. His is currently Principal Investigator on two NIH sponsored studies of tobacco control among veterans and activity duty military personnel. In addition, he serves as the biostatistician for several epidemiological studies and randomized clinical trials. His professional affiliations include the American Statistical Association (Accredited Professional Statistician), the National Strength and Conditioning Association, Association of Military Surgeons in the U.S., and the Society for Research on Nicotine and Tobacco. He was awarded Fellow status in the Obesity Society for his research on nutrition and weight control. Dr. Haddock has been honored in Who's Who in America, Who's Who in Medicine and Health Care, and Who's Who Among America's Teachers. In his leisure time he earned a blackbelt in Busihidokan Karate and has studied Wado-Ryu, American Jiu Jitsu, and Muay Thai and is a certified CrossFit trainer.
, is Director of the North Carolina office of NDRI, the Institute for Community-Based Research (NDRI-NC). The Institute for Community-Based focuses exclusively on drug abuse treatment research. He is the principal investigator on the Clinical Trials Network (CTN); and has been principal investigator on the Drug Abuse Treatment Outcome Study (DATOS), an ongoing national study of drug abuse treatment and the Treatment Outcome Prospective Study (TOPS), an earlier study initiated in 1976. From 1989 to 1996 he was project director for the Methadone Quality Assurance Project (MTQAS). Dr. Hubbard has demonstrated a career-long commitment to the advancement of science in the drug abuse treatment research field. He and his colleagues authored the book Drug Abuse Treatment: A National Study of Effectiveness, UNC Press, 1989, as well as numerous other studies of alcohol and drug abuse and research methodology. He served on the Institute of Medicine Committee on Substance Abuse Treatment Coverage and on the National Research Council Panel on the Evaluation of AIDS Interventions. He is a member of the Board of Directors for the Governor's Institute on Alcohol and Drug Abuse. Dr. Hubbard is an acknowledged expert on alcohol and drug abuse survey research methodology, research design, and methods of validating self-reports. He has formal training and considerable experience in psychometric theory, field-based randomized clinical trial designs, survey research design, and multivariate statistical analysis, as well as qualitative case study approaches.
, is a Principal Investigator with the Institute for Biobehavioral Health Research and Director of the Center for Fire, Rescue & EMS Research at NDRI. She completed her doctorate in Counseling Psychology with a Health Emphasis at the University of Missouri – Kansas City and the American Heart Associations’ Fellowship on the Epidemiology and Prevention of Cardiovascular Disease. Dr. Jahnke served as the Principal Investigator of two large-scale studies of the health and readiness of the U.S. Fire Service and has published research on health behaviors of military personnel. She currently serves as the Principal Investigator of a study focused on the health of women firefighters funded by the National Heart, Lung, and Blood Institute. Dr. Jahnke has published both qualitative and quantitative articles in the areas of obesity, tobacco, and health behaviors. She has served as a the principal investigator or co-investigator for a number of studies funded by the Department of Homeland Security, the National Institutes of Health, and the American Heart Association. She is an active member of the Safety, Health and Survival section of IAFC and is called on regularly to be a consultant on health related topics for that committee. She was invited to author a white paper for the 3rd Life Safety Summit of the Everyone Goes Home program from the National Fallen Firefighters Foundation, chaired the health and wellness section of the 2nd National Fire Service Research Agenda Setting Symposium, as well as authored a book chapter on health and wellness among firefighters for the Everyone Goes Home text book.
is a Project Director at the Institute for Biobehavioral Health Research at NDRI. She received her doctorate in Health Psychology from the University of Missouri-Kansas City in 2009, and completed her postdoctoral research fellowship in the NIH-funded Behavioral Sciences Training Program in Drug Abuse Research (5T32DA007233) at Public Health Solutions/NDRI. Dr. Jitnarin’s research primarily focuses on both health behavior (e.g., diet, exercise) and addictive behavior research, particularly tobacco use. Dr. Jitnarin has a strong background in study coordination and experience in the area of health outcomes research, specifically in statistics, epidemiology, and food and nutrition, as well as health-related behaviors. In addition, she has been involved in the conduct and analysis of a number of large studies including cohort/observational studies and randomized controlled trials. Currently, she serves as the Project Director of two NIH-funded studies focusing on tobacco control: Enhancing civilian support for military tobacco control and Barriers to Effective Tobacco Control Policy Implementation in the US Military.
, is an internationally recognized expert in addiction recovery. Her federally funded research in the past 15 years has focused on elucidating what helps people with drugs and/or alcohol problems quit drinking or getting high and how they stay in recovery. A social psychologist, her main goals are to build the science of recovery and to help translate findings into services and policy that create opportunities for long-term recovery and improved quality of life for people with substance problems. She leads the Center for the Study of Addictions and Recovery at National Development and Research Institutes, Inc. (NDRI) and provides training and consultancy to government and community-based agencies on promoting opportunities for sustained recovery. She regularly publishes in peer-reviewed journals, presents at national and international conferences, and serves on the editorial board of several scientific publications.
, is a Senior Principal Investigator in The Institute for Special Populations Research and in Social Science Innovations Corp., the for-profit sister organization to NDRI. He is a licensed psychologist specializing in measurement of drug use by various means and the statistical evaluation of social programs. He received his PhD in 1986 from the City University of New York. He has been a principal investigator on a variety of projects including a study to test a slightly heated sweat collection device called a Fastpatch. This project, "Detecting Crack and Other Cocaine with Fastpatches," was the first study to detect unique crack pyrolysis metabolites in sweat which form when crack is smoked or cocaine is freebased. When this product is marketed, it will allow testers to not only determine if cocaine was used, but also if the mode of consumption was through smoking. He also was Principal Investigator on a meta-analysis grant comparing self-report of tobacco, alcohol, and illicit drug use with biological indicators (e.g. urinalysis) or collateral reports (e.g., spouse, case worker) and will produce an accessible database available from a website. His earlier research evaluated the effectiveness of a specialized therapeutic community (TC) for homeless, substance abusing men operated from a public shelter. His publication from this project "Dynamic Recovery" is one of the more frequently sited (e.g. NIDA Notes) examples of a successful adaptation of the TC model for a special population. Currently, he has several projects to develop online, interactive courses about topics related to substance abuse and HIV including "HIV Confidentiality Training" for New York State service providers and "Using CAI to Enhance Drug Tx Staff HCV Knowledge and Communication Skills," “Web-based Course on Traumatic Brain Injury and Substance Abuse” and “Online Training for Methadone Maintenance Treatment Providers.” Each of these courses, when they go online in 2010 will be self-directed, allowing individuals to proceed at their own pace. They will be highly interactive, with prompts, questions, case studies implemented with audio and video as well as interactive graphics. These courses will be tailored, allowing individuals to match the level and type of detail to their specific job function including examples and case studies that pertain to their particular occupation. As a check on content covered and learned, quizzes will be administered throughout the course and certificates of completion will be given to individuals stating both the modules and specific content areas completed.
is Director of the Training Institute at NDRI. He has over 20 years experience in training, curriculum writing, program development and management specializing in the public health fields of substance abuse and sexually transmitted infections including HIV/AIDS. Mr. Lunievicz has lead training initiatives and curriculum writing teams on HIV and Drug Treatment Curriculum including the following regional and national training initiatives: Cultural Prificiency Issues, Care Coordination for Adherence to HIV, and Consensus and Evidence Based Practices for Co-Occurring Mental Health and Substance Abuse Disorders. In addition to managing both regional and national projects he has worked extensively with local and national drug court initiatives specializing in Cultural Proficiency Issues, Treatment Modalities, Teambuilding, Presentation Skills, and Understanding and Coping with Participant Relapse. He has presented at the National Association of Drug Court Professionals annual conference and at state conferences across the country. Mr. Lunievicz is also co-investigator on a number of NIDA funded projects to develop computer assisted training on subjects such as: The New York State HIV Confidentiality Law, Methamphetamine Treatment for Drug Court Practitioners, Hepatitis C Knowledge and Communication Skills for Drug Treatment Workers, Traumatic Brain Injury and Substance Abuse, and Methadone Maintenance Treatment Practitioner Knowledge and Values. In addition Mr. Lunievicz has been a curriculum collaborator and trainer on a number of other research and intervention projects. Mr. Lunievicz has also spent years overseas in the United States Peace Corp in Central American where he conducted cross cultural projects with small businesses and health promotion programs and speaks Spanish as a second language.
is a sociologist with over fifteen years of research experience in New York City and internationally, spanning the epidemiology of drug use, urban studies, crime, immigration, social networks and HIV/HCV prevention.
At the Vera Institute, Dr. Mateu-Gelabert was lead researcher of a National Institute of Justice grant that focused on adolescent violence, gangs, and immigration. At NDRI at the Institute for Infectious Disease Research, he has led multiple projects including, as Principal Investigator, Staying Safe, an intervention funded by NIDA, which trained injection drug users in strategies and practices to avoid HIV and HCV infections. Dr. Mateu-Gelabert is currently leading a five-year (2013-2018) NIDA- funded study: HIV, HCV, and STI Risk Associated with Nonmedical Use of Prescription Opioids. This mixed-methods study aims to assess the drug and sex-related HIV/HCV and STI risk associated with nonmedical prescription opioid use among young adults. He is also collaborating with several interdisciplinary teams on various projects related to HIV/HCV prevention and drug use epidemiology, including work with New York City Department of Health, New York University and Universidad de CES (Medellín, Colombia).
Dr. Mateu-Gelabert has over fifty peer-reviewed publications and has given numerous scientific presentations throughout the world. He was visiting professor at Hunter College School of Public Health and has provided seminars at several universities. In addition to his research and teaching experience, he is also a founding member of the Social Art Collective, a group that merges artistic and professional expertise using art as a conduit to generate social change.
a Project Director and Co-investigator with NDRI’s Institute for Treatment and Services Research, is currently the Project Director of Challenges to Opioid Treatment Programs after Hurricane Sandy: Preparedness, Planning, and Recovery Efforts, a study funded by the office of the Assistant Secretary for Preparedness and Response at the US Department of Health and Human Services. Other current research includes examining prescription drug diversion through The Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System, an independent, nonprofit operation of the Rocky Mountain Poison and Drug Center (RMPDC), a division of Denver Health.
Previously, Dr. Matusow served as the Project Director on a nationwide survey of US Drug Courts on barriers, attitudes, and availability of medication assisted treatment in drug courts. The results of this survey are cited in the National Association of Drug Court Professionals Best Practice Standards of 2013 as a rationale for a policy statement that Drug Courts learn about medication assisted treatment and obtain expert consultation from addiction physicians. As chair of the symposium entitled Drug Court Perspectives: Adopting Operational and Evidence Based Practices at the 2012 Addiction Health Services Research conference in New York City, Dr. Matusow moderated the discussion of evidence-based practices in Drug Courts with colleagues from the field and conducted a Webinar on MAT for the Center for Court Innovation, on which he serves on the Advisory Committee. Other research interests include dual focus mutual aid for those with co-occurring mental health and substance use disorders.
In Dr. Matusow’s capacity as both clinician and researcher, he has a special interest in implementation science – research to practice – and the challenges associated with bringing evidence-based practices into therapeutic settings.
is the Program Manager at the Training Institute at NDRI. Her responsibilities include training and managing on and off-site contract trainings. She worked on the COCE (Co-Occurring Center for Excellence) where she developed a training matrix to assess training curricula on co-occurring disorders and developed trainings on evidence-based and consensus-based practices for persons with COD. She trained trainers and providers on TIP #42 nationally. Mary is a training consultant on substance abuse, mental illness, HIV, and vocational rehabilitation. She has worked for a number of agencies nationwide: Center for Addiction and Substance Abuse at Columbia University (CASA), National Association for Drug Abuse Problems (NADAP) and the National Drug Court Initiative (NDCI). Mary has worked with several government agencies such as Probation, Social Services and the Peace Corps. She worked at Gracie Square Hospital on their substance abuse unit “Breakthrough” and the “Dual Focus” unit. She is a Certified Rehabilitation Counselor (CRC) and has worked as a rehabilitation counselor in hospitals and agencies in New York. Mary was a Peace Corps volunteer in Oman and a Peace Corps trainer in Yemen, Oman, and Morocco.
Mary teaches at New York University in the Department of Applied Psychology. She has a Master's degree from NYU and a Bachelor degree from the State University of New York at Albany.
specializes in the development of instruments which measure the effects of various research activities. His initial work, supported by federal funding, compared motivation and readiness for treatment across several special populations of substance abusers, and resulted in the Circumstance, Motivation and Readiness Scales, which measures motivation in different substance abuse treatment modalities. Subsequent research developed the Client Matching Protocol to characterize client referrals to outpatient and residential substance abuse treatment programs, and the Survey of Essential Elements Questionnaire (long and short forms) that measures the extent to which programs utilize the elements of therapeutic community treatment. At present, Dr. Melnick is engaged in programmatic research to evaluate the effectiveness of prison- and community-based substance abuse treatment programs through the application of the Multi-modality Quality Assurance Instrument, which he developed to generate a better understanding of organizational characteristics, program policies, and treatment goals and elements. Within this effort, he is investigating the role of organizational variables in substance abuse treatment efficacy, and is developing additional instruments to assess the use of therapeutic community treatment elements. Dr. Melnick is also making substantial contributions to two criminal justice studies, one to evaluate the effects of stigma on recidivism among first time nonviolent felons; the other a national initiative to conduct multi-site studies of the correctional system. Dr. Melnick has been with NDRI since 1991 and on staff at the Center for the Integration of Research Practice since its inception.
International AIDS Society and the National Institute on Drug Abuse. Under the Fellowship, Dr. Nikolopoulos will be mentored by Dr. Samuel Friedman, Director of the Institute for AIDS Research at NDRI. Dr. Nikolopoulos will initially get training in social research methods and will later be involved in research on the recent HIV outbreak among drug injectors in Greece. Dr. Nikolopoulos has served at the Greek public health agency for almost one decade, focusing on HIV surveillance. He earned a PhD in the epidemiology of infectious diseases at the School of Medicine of the Athens University in Greece. He has extensively investigated the dynamic characteristics of HIV transmission in Greece, including the molecular parameters of the epidemic. Dr. Nikolopoulos has also studied the long-term impact of hepatitis B virus co-existence on AIDS and mortality in the context of a large-scale retrospective cohort study. He has also studied the impact of the recent influenza pandemic trying to explain the differential effects of A (H1N1) virus on mortality across European countries. The findings of his study pointed to the association of per capita governmental spending on health with influenza-related mortality. Dr. Nikolopoulos also has high-level expertise in the conduct of systematic reviews and meta-analyses with useful contributions to the evolving domain of genetic epidemiology.
is the Cultural Proficiency Program Manager for the Training Institute of the National Development & Research Institutes, Inc. Ms Padilla manages the ‘Cultural Proficiency for Drug Court Practitioners’ and the Hepatitis C training projects.
Ms Padilla is a Senior Trainer with over 14 years of experience in public health. She has worked in the substance abuse treatment field as well as with community based organizations offering HIV/AIDS services to the Latino and African American communities where she also created and became the agency’s Domestic Violence liaison. Ms Padilla has trained public health workers, treatment specialists, and drug court practitioners on topics of Cultural Competency, Substance Abuse, Women’s Issues, Case Management, Treatment Modalities, Harm Reduction, Stages of Change, Outreach, HIV/AIDS, Domestic Violence, and Viral Hepatitis.
Ms Padilla developed the curricula and trains the 'Cultural Proficiency with Latinos in Drug Court Practice,' and is the co-developer of the ‘Integrating a Veteran Treatment Court into an Existing Problem-Solving Court Model.’ She was a part of the development team for the NIAAA funded “Supporting Alcohol Reduction In HIV+ Patients: A Training For HIV Care Providers” and` NIDA funded projects such as, “Online Methamphetamine Abuse Training for Drug Court Professionals,” “Web-based Course on Traumatic Brain Injury and Substance Abuse,” and “Mandated HIV Service Provider Confidentiality Training.”
Ms Padilla presents workshops for the National Association of Drug Court Professionals, Addiction Treatment for Providers Association of New York State, and as a training consultant for the National Drug Court Institutes, Family Treatment Courts conferences of Skagit County, Washington, Supreme Court of Virginia, AIDS Related Community Services and AIDS Community Research Initiative of America.
, is a Senior Principal Investigator at that National Development and Research Institutes (NDRI) and serves as Deputy Director for the Institute for Biobehavioral Health Research at NDRI. He has graduate degrees in the behavioral sciences (University of California, Santa Barbara) and in community health and epidemiology (University of Texas Houston Health Science Center, School of Public Health). Dr. Poston completed postdoctoral fellowships in Behavioral Health Psychology (Wilford Hall Medical Center) and in Cardiovascular Health (American Hospital Association Health Forum). His research focuses primarily in the areas of obesity, tobacco control, and cardiovascular disease prevention with an emphasis on minority populations and military and first-responder health. He has been a principal investigator or co-investigator on grants from the American Heart Association (AHA), the American Legacy Foundation, the National Heart, Lung, and Blood Institute, the National Institute of Digestive Disorders and Kidney Diseases, the Agency for Healthcare Research and Quality, the Department of Defense US Army Medical Research and Material Command, and the Department of Homeland Security/FEMA. He also has been the recipient of a Minority Scientist Development award from AHA. Dr. Poston has served as a charter member on the National Institutes of Health’s (NIH) Community Level Health Promotion Study Section and as an ad hoc member on a number of other NIH study section and special emphasis panels. He is a Fellow of the American College of Epidemiology, the American Heart Association’s Council on Epidemiology and Prevention, and The Obesity Society: the North American Association for the Study of Obesity. He was a Cardiovascular Health Fellow with the American Hospital Association’s Health Forum (2001-2002). Dr. Poston has published over 170 peer-reviewed journal articles and book chapters and has presented at numerous national and international conferences and meetings on the etiology, assessment, and management of obesity, cardiovascular disease, and tobacco use.
is an epidemiologist whose work is focused on social determinants of health and racial/ethnic health disparities. His research includes studies of mental disorders, substance use, and transmission of infectious diseases, such as HIV and hepatitis C, through social networks and populations. He is an experienced methodologist and quantitative analyst, with expertise in clinical assessment, scale development, clinical trials, survival analysis, mixed effects modeling, meta analysis and agent-based modeling. Dr. Pouget is currently funded by the National Institute on Drug Abuse as a Principal Investigator of a study to develop new measures of the pathways between social structural changes and HIV epidemics, and as a Co-Investigator of a study to assess change over time in risks of opioid misuse and overdose among recent US military veterans.
, is a Project Director in the Institute for Special Population Research. She is currently working on a project that examines co-parenting among cohabiting low-income black couples with children who live in high poverty areas in New York City (R01HD064723, PI: Andrew Golub, PhD). The study seeks to examine how the family formation paradigm of transient domesticity influences parenting decisions, parental responsibilities, and child development. It employs the mixed-methods approach of a longitudinal panel study and an embedded ethnography over a five year period. Dr. Reid received her PhD in sociology from the University of Texas at Austin, where she focused on social inequalities, family, and social policy. Her work has appeared in publications such as the Journal of Family Issues and Sociology Compass.
, is NDRI’s Executive Director as well as the Director of NDRI’s Institute for Treatment and Services Research at NDRI. His research addiction-related interests include development and evaluation of psychosocial interventions, eLearning and eTherapy applications, and prevalence studies. Most of his research activities have been funded by the NIH. Recent and current projects include a survey and a clinical trial of agonist medications in the criminal justice system , a clinical trial on the use of buprenorphine to treat chronic pain, a randomized clinical trial of self-help groups designed for consumers with co-occurring substance use and mental health disorders (Double Trouble in Recovery; DTR); a nationwide prevalence study of prescription opioid abuse, and web-based self-management interventions for chronic pain patients and PTSD symptomatic substance-misusing veterans Dr. Rosenblum is also PI on a Health and Human Services grant designed to develop policy recommendations for emergency preparedness and response for opioid treatment programs and, is a Co-investigator (Dr. Alexander Bennett is PI) on a prospective longitudinal study that is examining factors contributing to overdose among young veterans.
Dr. Sacks has garnered exceptional administrative, managerial, and multi-site research expertise during nearly three decades of clinical, programmatic, and research activities. As Deputy Executive Director of a New York City treatment agency with a staff of over 250, Dr. Sacks led the development and supervised the operation of a continuum of 22 residential and outpatient treatment programs for homeless men and women with co-occurring mental health and substance use disorders. In her role as Deputy Director of the NDRI Center for the Integration of Research and Practice (CIRP) and Principal Investigator at NDRI, she has been actively involved in federally-funded studies of addicted women and men (with and without co-occurring mental disorders) who are also homeless, living with HIV/AIDS, or in the criminal justice system. Her research places special emphasis on the gender-specific issues (such as trauma and abuse) of addicted women in criminal justice and community treatment, and on the effect of the sequela of substance abuse on children and the family unit. During the past decade, she has managed nine research projects conducting multi-site evaluations of treatment programs for substance abusing individuals, many with co-occurring mental illness. Dr. Sacks also has provided leadership to a federally-funded national center of excellence in co-occurring disorders, providing technical assistance and training that assisted 39 states in improving their infra-structure and treatment capacity for serving individuals with COD. She currently provides similar technical assistance leadership for the NYSHealth Foundation “Center of Excellence in Integrated Care” for New York State residents with co-occurring disorders.
, a clinical-research psychologist, is the Director of the Center for the Integration of Research & Practice at National Development and Research Institutes (NDRI), Inc. in New York City. Dr. Sacks and the staff of CIRP specialize in technology transfer that infuses evidence- and consensus-based approaches into clinical practice. He is currently the Principal Investigator on several NIDA and SAMHSA- funded studies and Co-PI on the NDRI Rocky Mountain Research Center of the NIDA-funded Criminal Justice Drug Abuse Treatment System. The author of numerous publications, Dr. Sacks was the Chair and Lead Author for the Treatment Improvement Protocol #42, Substance Abuse Treatment for Persons With Co-Occurring Disorders. He is also Expert Leader on SAMHSA’s Co-occurring Center for Excellence, a national effort to provide training and technical assistance to States and agencies in the area of co-occurring disorders. Dr. Sacks, a baseball aficionado and weather maven, is married and the father of two children. He has four grandchildren.
, is an ethnographer and Principal Investigator who specializes in HIV and overdose prevention. She has worked extensively with people who use drugs (heroin, opioid analgesics, cocaine) and been involved in research in the following topic areas: women, poverty and AIDS; drug-using couples; drug use initiation; barriers to drug treatment; overdose prevention; trauma and secondary trauma; intimate partner violence; and, field-based research ethics. Dr. Simmons is co-editor and co-author (with Drs. Paul Farmer and Margaret Connors) of Women, Poverty and AIDS: Sex, Drugs and Structural Violence (1996; 2011) which received the Eileen Basker Memorial Prize for outstanding scholarship in gender and health from the Society for Medical Anthropology, American Anthropological Association. She has worked on a variety of NIDA-funded prevention studies in Hartford, Connecticut (Hispanic Health Council) and New York City (NDRI). Since 2008, Dr. Simmons has been the Principal Investigator on several NIH grants, including an HIV prevention study on the interpersonal and structural dynamics which shape HIV risk and drug treatment among injecting, drug using couples in Harlem and the South Bronx. She has also expanded her advocacy and training interests. She has developed two computer-based, overdose-prevention training modules with funding from NIDA: one for potential bystanders (family, friends, anyone who may witness an overdose); and one for police officers, firefighters and EMTs. Dissemination of these online training modules will soon be underway. Currently, Dr. Simmons is an affiliated researcher with the Center for Drug Use and HIV Research at New York University and an Advisory Board and faculty member at the Fordham University HIV Prevention Research Ethics Institute.
Dr. Barbara Tempalski, Co-Principal Investigator, Institute for Infectious Disease Research, National Development & Research Institutes, Inc., New York, NY. She broadly identifies as a health and social geographer. Her research interests include infectious disease, women's health, political ecology of health and disease, disease surveillance, health policy and global health. Her research expertise lies in studying the distribution of HIV and identifying the sociopolitical and structural responses to these distributions.
Her current research investigates injection drug use-related HIV, and measuring the need for service provision and availability of services to this highly stigmatized and largely hidden population. This research focuses on the nexus of health, social, and political geography in measuring the geographic distribution of services, response and prevention of HIV among injection drug users.
Dr. Tempalski served as a consultant for USAID evaluating the utility of GPS and GIS as a tool for integrating schistosomiasis control in Egypt. She also worked for UNICEF examining the utility of a GIS in evaluating Dracunculiasis eradication policies in West Africa. She has conducted reproductive health research in Nepal focusing on use of condoms and HIV knowledge among Nepalese women, and how physical landscape bears on this knowledge.
Dr. Tempalski earned a Ph.D. in Geography in 2005 from the University of Washington, Seattle, WA. She earned an M.A. in Geography at Hunter College of the City University of New York in 1992, and an M.P.H in Community Health Education at the same institution in 1997. She completed a B.A. degree in Geology from Northeastern University, Boston, Mass in 1984.
She has a growing list of publications in journals like Journal of Urban Health, American Journal of Public Health, and Journal of the American Medical Association and Journal of International Drug Policy.
has been involved in drug treatment program planning, research, evaluation and outcome studies since the late 1980s. His professional expertise includes interviewer training, coordinating longitudinal follow-up studies, and locating and interviewing hard to reach populations for clinical and research purposes. His award winning doctoral dissertation in Criminal Justice (Reisenbach Foundation Award) investigated the long-term recovery process from heroin use and focused on ex-offenders who maintained abstinence for a period of five or more years. He served as an evaluator of several prison-based therapeutic communities for the Office of National Drug Control Policy, and consults for various research organizations on Research Interview Design, Quality Control, and Interviewer Training and Administration. He is a Research Scientist member of the National Hispanic Science Network on Drug Abuse (NHSN) and is one of the founders and former Editor of the NHSN Newsletter El Faro: La Voz de la Red. He is Chair Emeritus of the NHSN Early Career Leadership Committee and is an active member of that committee. Dr. Tiburcio is a former Project Director on several federally and privately funded studies in the Institute for Treatment Services Research at NDRI. The NIDA-funded STOP HEP C Project examined the nationwide drug treatment response to the hepatitis C virus. Project STAR, an acronym for “Staff Training on Alcohol Reduction,” was devoted to the development of a state-of-the-art HIV care provider training to encourage the implementation of NIAAA’s screening and brief intervention (NIAAA’s BI) in Designated AIDS Centers (DACs) in New York City. He also served as Co- Investigator of a NIDA funded study designed to systematically study changes in illicit drug markets (including use and distribution) resulting from Hurricane Katrina in Aug 2005. Presently, Dr. Tiburcio is Principal Investigator in NDRI's Institute for Special Populations Research of a NIDA study examining sustained abstinence from opioid use, and the social and structural support mechanisms available to HIV+ respondents in NYC.
Institute for Special Populations Research. Since 2004, he collaborated on a number of NIH-funded research studies, e.g., drug abuse treatment effectiveness meta-analysis, study of a modified TC aftercare for triply diagnosed population, and analysis of staying-safe strategies of long-term injection drug users. He trained as a Psychologist and received his Doctoral Degree from the New School for Social Research in 2006. During his Postdoctoral Fellowship in the Public Health Solutions/NDRI Behavioral Sciences Training Program (2008–2010), funded by NIDA, he developed international research collaborations to examine inhalant use among the Roma (Gypsy) population, the largest minority of Europe. The results of his pilot data collection project conducted in eastern Slovakia (funded by IREX) were published in a special issue of Substance Use & Misuse. Currently, Dr. Vazan collaborates as a data analyst with Dr. Andrew Golub on two five-year longitudinal panel studies: Veteran Reintegration, Mental Health, and Substance Abuse in the Inner City (funded by the National Institute on Alcohol Abuse and Alcoholism) and The Impact of Transient Domesticity Coparenting in Poor African American Families (funded by National Institute on Child Health and Human Development).is a Senior Research Associate at the
, created, and is currently the Program Manager for the LGBT Health Aware Project in the Training Institute at the National Development and Research Institutes, Inc. (NDRI). He is also a freelance consultant and has over 19 years experience in education, training facilitation, curriculum development/writing, technical assistance, and program development/management. Mr. Warrens’ current responsibilities in the Training Institute include curriculum development, training facilitation, managing on and off-site contract trainings and technical assistance interventions. Prior to his current responsibilities at NDRI, he created and managed the Technical Assistance Program (TAP). TAP work included the development of HIV/AIDS specific curricula and delivery of trainings targeted to build staff and organizational capacities. Mr. Warren has written curricula on: Stress Management and Vicarious Trauma-1 day and ½ day versions, Team Building, Working with LGBT Clients – Tools for Effective Care, Working with LGBT Clients in Treatment and Recovery, and Homophobia Reducing the Harm and Risk. Additionally, he has reviewed and tailored a wide range of existing curricula to meet specific needs of technical assistance recipients. Areas of content expertise include and are not limited to: HIV/AIDS, HIV Treatment Adherence, HIV Disclosure, Counseling Skills, Group Work, Team Building, and LGBT Competent Practice. Prior clients include and are not limited to: The Centers for Disease Control, Iris House, Asian Pacific Islander Coalition on HIV/AIDS, Narcotics Rehabilitation Center, The Chinese American Planning Council, and Gay Men’s Health Crisis. Mr. Warren served on the New York City HIV Prevention Planning Group as a community representative for four-years. He has a Master’s degree in Social Work from Hunter College School of Social Work and a Bachelor’s degree from New York University.
, has acquired a national reputation in the areas
of substance abuse policy, treatment and research during the last 35 years.
He is best known for his landmark studies of the effectiveness of the therapeutic
community in the community, prisons and aftercare, which established prison
treatment programs in 20 states. Often credited with contributing to the
acceptance of prison-based drug treatment nationwide, this research demonstrated
the effectiveness of prison treatment particularly when coupled with aftercare,
and has had considerable impact on the field. The California Department
of Corrections presented Dr. Wexler with a Pioneer Award in recognition
of his role in expanding aftercare services for offenders. Dr. Wexler was
the Co-Chair of a recent Treatment Improvement Protocol, Substance Abuse
Treatment for Adults in the Criminal Justice System, and is the Principal
Investigator on two current government-funded projects studying elements
of prison treatment, community re-entry, and the effectiveness of sealing
records as a method of reducing recidivism by eliminating stigma. He has
written numerous articles, has co-authored a book on substance abuse treatment
for women, and has served as co-editor of special issues of the Prison
Journal. In June 2007 Dr. Wexler was appointed as a member of the Governor's Strike Team to help guide the process of reforming the California correctional system. Dr. Wexler has been with NDRI since 1977 and a senior staff member of the Center for the Integration of Research Practice since its inception.
Currently, Dr Wexler is retired from his 32 year career at NDRI while serving as an NDRI project consultant. He is also practicing clinical psychology in New York and Laguna Beach, writing a book on later male development, and is a blogger for Psychology Today. He also lectures internationally and serves as an advisor for correctional and rehabilitation policy in the US and other countries.
, is a Program Manager in NDRI’s Training Institute working on the Care Coordination Protocol Training funded by New York City under the Ryan White HIV/AIDS Treatment Extension Act. Ms. WIlliams has experience as a program director for an AIDS services program that offered case management, prevention education, transitional services and support group services for HIV+ persons with a history of substance use. Over the last 19 years, Ms. Williams has performed curriculum development, grant writing and managed various projects committed to addressing the HIV epidemic in communities of color.
She has conducted trainings throughout New York State and has 15 years of training experience in the field of public health, HIV/AIDS services, substance use and social services. Ms. Williams has worked as a trainer within NDRI’s Training Institute, the Center for Public Health Education at Stony Brook University, the AIDS Community Research Initiative of America (ACRIA), and McNamara & Associates training competencies related to organizational development.
Ms. Williams is an expert on cultural issues and has experience working with various audiences delivering topics such as Diversity, Cultural Competence, Leadership Training, Handling Difficult Client Behaviors, Conflict Resolution, and Domestic Violence.
is Project Director of the Collaborative Hepatitis Outreach and Integrated Care Evaluation Study (CHOICES) in NDRI's Institute for Infectious Disease Research. She has been working in the field of harm reduction and public health since 1996 when she began doing outreach with sex workers in Washington, DC. After moving to New York in 1997 she became involved with ACT-UP and later worked as Harm Reduction Coalition’s National Training Coordinator from 2001-2003. From 2004-2010, Emily worked with the SWAN Project, an epidemiological study investigating the behavioral and biological correlates of hepatitis C infection among younger injection drug users in New York City, first as a Research Assistant/Field Site Supervisor and later as Project Director. Emily was responsible for Resource Development and Communications at Harm Reduction Coalition from 2010-2013, where she authored policy reports, training curricula and educational materials as well as maintained website content and administration. She is a passionate harm reductionist (both personally and professionally), occasional trainer and has presented at conferences nationally and internationally. Emily received a BA in Criminology and Criminal Justice and a Certificate in Women's Studies from the University of Maryland and obtained her Masters of Social Work degree in 2001 from Hunter College School of Social Work in New York City.
CHOICES is a randomized trial of a novel multidisciplinary, integrated care program carried out in collaboration with a community-based needle exchange program in Harlem that provides antiviral therapy for hepatitis C to persons who inject illicit drugs.